MILLENNIUM MANAGEMENT LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 62 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$157
-100.0%
174,994
+181.7%
0.00%
Q3 2022$373,000
+33.2%
62,116
+3.3%
0.00%
Q3 2021$280,000
-72.0%
60,108
-57.6%
0.00%
-100.0%
Q2 2021$1,000,000
+1036.4%
141,783
+849.7%
0.00%
Q1 2021$88,000
-50.8%
14,930
-67.5%
0.00%
Q3 2020$179,000
-13.5%
45,926
+538.7%
0.00%
Q2 2020$207,000
-60.6%
7,190
-79.5%
0.00%
-100.0%
Q3 2019$525,00035,0380.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders